Farther Finance Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History

Farther Finance Advisors’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20	Closed	-$797	–	6001
2026 Q1	$797	Sell	20 -402	-95%	-$10.3K	﹤0.01%	5165
2025 Q4	$10.6K	Buy	+422	New	+$10.7K	﹤0.01%	3871

Farther Finance Advisors's CNTA Position: Q2 2026 in Review

Farther Finance Advisors sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 20 shares — an estimated $797 sold.

Farther Finance Advisors first reported a position in CNTA in Q4 2025 and held it in 2 quarters. The position peaked at $10.6K in Q4 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Farther Finance Advisors reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Farther Finance Advisors sold 20 Centessa Pharmaceuticals shares in Q2 2026, an estimated $797.
Farther Finance Advisors first reported a position in Centessa Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Farther Finance Advisors's Centessa Pharmaceuticals position peaked at $10.6K in Q4 2025.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.